According to the statutory definition, health technology means medicinal products, devices, diagnostic and therapeutic procedures used in certain indications, as well as organizational support systems within which healthcare services are provided.
Matters of health technology assessment are governed by two legal acts:
- the Act of 27 August 2004 on healthcare services financed from public funds and
- the Act of 12 May 2011 on the reimbursement of medicinal products, foodstuffs for particular nutritional purposes and medical devices.
Due to differences in the approach to the assessment of drug and non-drug technologies, health technologies are assessed by two departments of the Agency:
- Health Technology Assessment Department and
- Services Department.
The former specializes in drug technology assessment, while the latter specializes in non-drug technology assessment. Details on the methodological solutions for the assessments performed, along with their results, are available under separate tabs.
Please refer to the Public Information Bulletin for documents regarding the substantive scope currently being processed.
*Ladies and Gentlemen
We inform you that the materials and results of the discussions posted on the Agency’s website are the result of the conceptual work and analytical process carried out by the team of the Agency for Health Technology Assessment and Tariff System based on the EBM paradigm, including: search, selection, synthesis and interpretation of scientific evidence, or the data analysis carried out.
In connection with the above, we would like to inform you that the use of analytical material or the results of the discussion, in accordance with good practice, should be accompanied by information on the source in the form: [title of presentation / report], AOTMiT, Warsaw, June 2021]